Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Total Environ ; 828: 154458, 2022 Jul 01.
Article in English | MEDLINE | ID: mdl-35278547

ABSTRACT

Yellow and dark mealworms (Tenebrio molitor and Tenebrio obscurus) biodegrade commercial polyethylene (PE) materials at a high rate. We examined the impact of physical and chemical properties on biodegradation using high purity microplastics (MPs). These included high-density polyethylene (HDPE), low-density polyethylene (LDPE), and linear low-density polyethylene (LLDPE), all with different weight average molecular weights (Mw) and different crystallinity degrees in T. molitor and T. obscurus larvae. The biodegradation extent in the two mealworms was similar but strongly depended on the polymer type in sequence, since LDPE > LLDPE> HDPE (with respective Mw of 222.5, 110.5 and 182 kDa). When LDPE MPs with Mw of 0.84, 6.4 and 106.8 kDa and HDPE with Mw of 52, 105 and 132.7 kDa were tested, the PE MPs with lower Mw showed a greater extent of depolymerization. The results of dominance analysis indicated that less branching structure and higher crystallinity degree negatively impacted depolymerization and biodegradation. Py-GC/MS analysis confirmed the breaking of the macromolecule backbone as well as the formation of oxidized functional groups after all the tested PE materials passed through the mealworm intestine. The results demonstrated that molecular weight, PE type, branching, and crystallinity degree significantly affect the biodegradation capability of PE by the mealworms, and possibly by other biological systems as well.


Subject(s)
Tenebrio , Animals , Biodegradation, Environmental , Larva/metabolism , Microplastics , Plastics/metabolism , Polyethylene/metabolism , Polystyrenes/metabolism , Tenebrio/metabolism
2.
Biol Pharm Bull ; 36(5): 764-71, 2013.
Article in English | MEDLINE | ID: mdl-23445942

ABSTRACT

Alzheimer's disease (AD), one of the most common forms of dementia, is primarily ascribed to the cholinergic deficits and neuronal dysfunction. Magnolol (Mag), a bioactivator extracted from Magnolia officinalis, has protective effects on cholinergic neurons, but the specific mechanism remains unknown. To further evaluate the therapeutic effects of Mag on the learning and memory impairment in a scopolamine (Scop)-induced mouse model, the passive avoidance and the Morris water maze tests, the measurement of the ratio of brain/hippocampus to body weight, activities of acetyl cholinesterase (AChE), superoxide dismutase (SOD), total nitric oxide synthase (total NOS) and the content of methane dicarboxylic aldehyde (MDA) in hippocampus homogenate as well as the immunefluorescence staining of the AChE positive nerve fibers were performed. Therapeutically treated with Mag, the impaired abilities of learning and memory of the Scop-induced mice were almost restored to the native levels. The restored AChE, total NOS and SOD activities and the MDA level were observed, with a relatively normal density of AChE positive nerve fibers in hippocampus CA3 molecular layer. The improving efficacy of Mag on learning and memory impairment induced by Scop is dose-dependent, indicating that Mag has potential neuroprotective effects against neuronal impairment and memory dysfunction induced by Scop in mice. The underlying mechanisms may be associated with the anti-oxidative effects of Mag and its protective effects on hippocampus cholinergic neurons.


Subject(s)
Avoidance Learning/drug effects , Biphenyl Compounds/therapeutic use , Lignans/therapeutic use , Maze Learning/drug effects , Memory Disorders/drug therapy , Neuroprotective Agents/therapeutic use , Acetylcholine/metabolism , Animals , Biphenyl Compounds/pharmacology , Brain/anatomy & histology , Brain/drug effects , Brain/metabolism , Cholinergic Neurons/drug effects , Cholinergic Neurons/physiology , Lignans/pharmacology , Male , Malondialdehyde/metabolism , Memory Disorders/chemically induced , Memory Disorders/metabolism , Memory Disorders/physiopathology , Mice , Nerve Fibers/drug effects , Nerve Fibers/physiology , Neuroprotective Agents/pharmacology , Nitric Oxide Synthase/metabolism , Organ Size/drug effects , Scopolamine , Superoxide Dismutase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...